SPOTLIGHT: Dabur gets nod for generic Camptosar

India's Dabur Pharma got the FDA's tentative OK to sell a generic version of Camptosar, Pfizer's colon cancer treatment. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.